Negative-pressure Wound Therapy (NPWT) Market size was valued at USD 2.56 billion in 2024 and is likely to reach USD 5.8 billion by 2037, registering around 6.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of negative-pressure wound therapy is estimated at USD 2.69 billion.
The growth of the market is primarily attributed to worldwide increasing prevalence of acute and chronic wounds. For instance, around 4% of all patients in hospitals throughout the world have a chronic wound. In most cases 70% of these wounds resurface, and 34% caused by infection.
Negative pressure wound therapy, also referred as vacuum aided wound closure, is used for wound healing and fluid removal from the site of an open wound. NPWT is a non-invasive procedure that employs controlled negative pressure. These devices are frequently used in the treatment of diabetic foot ulcers, venous leg ulcers, and surgical wounds. Thus growing number of surgeries are fueling up the growth of the negative-pressure wound therapy (NPWT) market in the forecast period. For instance, every year, approximately 315 million major surgeries are performed worldwide, out of which, 40 to 51 million in the United States and 21 million in Europe.
Growth Drivers
Challenges
High Prices of the NPWT Devices
Base Year |
2023 |
Forecast Year |
2024–2036 |
CAGR |
6.5% |
Base Year Market Size (2023) |
USD 2.56 billion |
Forecast Year Market Size (2036) |
USD 5.8 billion |
Regional Scope |
|
The negative-pressure wound therapy (NPWT) market is segmented and analyzed for demand and supply by application into burn wounds, surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others, out of which, the diabetic foot ulcers segment is anticipated to significantly grow over the forecast period owing to the globally increasing prevalence of diabetic foot ulcers. For instance, the global annual incidence of diabetic foot ulcers ranges from 9 to 25 million.
Our in-depth analysis of the global market includes the following segments:
By Devices Type |
|
By Wound Type |
|
By Application |
|
By End-User |
|
Regionally, the negative-pressure wound therapy (NPWT) market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is predicted to hold largest revenue share by 2036, backed by rise in occurrence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers with the increase in geriatric population, increasing healthcare expenditure, and expanding research and development (R&D) activities in the region. According to the Centers for Medicare & Medicaid Services, national health expenditure is expected to rise by 5.1% per year from 2021 to 2030, reaching nearly USD 6.8 trillion.
2nd November, 2021: Medela LLC, patented Intelligent Pressure Control and Dynamic Exudate Removal Technology has proved its clinical effectiveness. Medela Invia LibertyTM Negative Pressure Wound Therapy (NPWT) System outperforms other multi-lumen NPWT systems available in the market.
3rd March, 2020: Smith & Nephew PLC, launched the new PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) which has a pump duration of up to 14 days.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?